Bioyitech's Health Science

The oral cavity serves as the body's primary defense line, intricately linked not only to daily functions such as eating, speaking, and breathing but also to overall systemic health. Oral health issues can precipitate local pathologies and may serve as a harbinger for systemic diseases, including cardiovascular and cerebrovascular conditions, as well as diabetes mellitus.

Starter cultures for food applications are microbial preparations containing at least one microorganism at a high cell concentration, which, when added to raw materials, control and accelerate the fermentation process in food production.

As Christmas approaches and winter descends, the significant temperature fluctuations between day and night not only send shivers down our spines but also heighten the risk of cardiovascular and cerebrovascular diseases.

Our intestines are not sterile environments. In addition to food and metabolic byproducts, they harbor a vast community of microorganisms, predominantly bacteria, which constitute 78% of the total human microbial load, collectively forming the gut microbiota.

Probiotics powder delivers beneficial live microorganisms to your gut. Their primary role is to help balance the gut microbiota, which supports digestive health, enhances nutrient absorption, and strengthens the intestinal barrier. Beyond basic gut function, specific clinical strains are researched for systemic benefits, including modulating immune responses and influencing metabolic health.

Probiotics improve disorders of glucose and lipid metabolism by modulating the structure of the gut microbiota, the function of intestinal epithelial cells, and the immune system.

Diabetes, often referred to as the "silent killer" in modern times, is experiencing a global surge, evolving into a significant public health concern.

A randomized, controlled trial was conducted, and specific pathogen-free mice were randomly divided into 4 groups: the control group (CON), the model group (MOD), the probiotic group (X11), and the active drug control group (ADC).

Bioyitech focuses on functional probiotic strains that improve "sugar-lipid metabolism," and is committed to improving endogenous metabolic capacity through probiotics.

Every 8 seconds, someone in the world is diagnosed with diabetes. However, scientists have discovered that by supplementing the gut with the right bacteria, glycated hemoglobin can be reduced by an additional 0.5%.